18983288589(微信同号)
18983288589(微信同号)
18908392210(微信同号)
18980413049
ChiCTR2400080109
正在进行
/
/
/
2024-01-19
/
/
ADHD
A Randomized Controlled Trial of Physical Activity Intervention on Neurocognitive Performance, Mental Health, and Behavioural Outcomes of Children with Attention Deficit Hyperactivity Disorder
A Randomized Controlled Trial of Physical Activity Intervention on Neurocognitive Performance, Mental Health, and Behavioural Outcomes of Children with Attention Deficit Hyperactivity Disorder
1. Examine the immediate, short- and longer-term effects of a school-based physical activity intervention on neurocognitive performance (inhibitory control, attentional control), mental health (anxiety and depression), and behavioural outcomes (e.g., social withdrawal and aggressive behaviour) in children with ADHD. 2. Determine the potential influence of the moderating variables (gender, ADHD subtypes) on the intervention effects.
整群随机分组
其它
Six schools will be cluster-randomized into either intervention schools or control schools using block size randomization in a 1:1 ratio. The random number sequence will be generated by an independent researcher. A computerized randomization tool will be used to create the random number sequence.
The results of the randomization will be kept confidential from the assessors.
Hong Kong University Grants Committee
/
60
/
2022-11-15
2025-11-15
/
(1) Children between the ages of 6 and 11 years diagnosed with ADHD, as defined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition; (2) capability to follow instructions of the researcher; (3) ability to carry out the prescribed physical activity intervention; (4) ability in reading and comprehending questionnaires; (5) no engagement in regular physical activity training within the last 6 months.;
登录查看(1) Presence of other medical conditions restricting physical activity capacities; (2) Presence of a complex neurologic disorder (e.g., epilepsy, fragile X syndrome); and (3) Visual and auditory deficits.;
登录查看The Chinese University of Hong Kong
/
施维雅2024-11-25
药明康德2024-11-25
药明康德2024-11-25
药渡2024-11-25
亚泰制药2024-11-25
Medaverse2024-11-24
小药说药2024-11-24
亚泰制药2024-11-24
BioArtMED2024-11-23
新康界2024-11-23